Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-29
DOI
10.1038/s41598-018-23808-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
- (2017) Nicole Stadler et al. HAEMATOLOGICA
- The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation
- (2017) Nicole Stadler et al. HAEMATOLOGICA
- Management of febrile neutropaenia: ESMO Clinical Practice Guidelines†
- (2016) J. Klastersky et al. ANNALS OF ONCOLOGY
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib
- (2015) Srinivasan Ramanathan et al. CLINICAL PHARMACOKINETICS
- Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1
- (2015) Christine B. Read et al. JOURNAL OF IMMUNOLOGY
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
- (2014) F. D. Roit et al. HAEMATOLOGICA
- The Multifaceted Functions of Neutrophils
- (2013) Tanya N. Mayadas et al. Annual Review of Pathology-Mechanisms of Disease
- Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils
- (2013) Jörn F. Dopheide et al. ATHEROSCLEROSIS
- Diverse novel functions of neutrophils in immunity, inflammation, and beyond
- (2013) Attila Mócsai JOURNAL OF EXPERIMENTAL MEDICINE
- TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors
- (2012) R. J. W. Arts et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Clinical Immunology Review Series: An approach to the patient with recurrent superficial abscesses
- (2010) S. L. Johnston CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Signaling Pathways of the TREM-1- and TLR4-Mediated Neutrophil Oxidative Burst
- (2009) Philipp Haselmayer et al. Journal of Innate Immunity
- TLR4/MyD88/PI3K interactions regulate TLR4 signaling
- (2009) Michelle H. W. Laird et al. JOURNAL OF LEUKOCYTE BIOLOGY
- TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines
- (2009) J. Kuai et al. RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search